Loading...
Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences
Patients suffering from hematological malignancies are at high risk for severe infections, including in particular bloodstream infections, which represent one of the most frequent life-threatening complications for these patients, with reported mortality rates reaching 40%. Furthermore, a worrisome...
Saved in:
| Published in: | Antibiotics (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168285/ https://ncbi.nlm.nih.gov/pubmed/32028615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9020058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|